Rising government initiative to enhance the development of multimodal or hybrid diagnostic imaging devices will create new opportunity for the market.

Recombinant human growth hormone (rhGH) market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to grow at a CAGR of 9.80% in the above-mentioned forecast period.

in the above-mentioned forecast period. Increasing number of programs to tackle NTD is expected to create new opportunity for the market.

Data Bridge Market Research analyses the market to grow at a CAGR of 3.20% in the above-mentioned forecast period.

Popularity of mHealth devices and introduction of advanced technologies for patient care and rising burden on pharmaceutical manufacturers to cut down overall costs for new drug development procedures are some of the factors which are aiding to the growth...

Growing investment in enhancement of healthcare IT including the solutions required for capturing data during clinical trials is boosting the market growth.

Presence of large number of pharmaceutical companies operating in the region willing to adopt new technologies in European countries is boosting the market growth in the region.

Growing digitization and transformation of infrastructure in the growing number of clinical trials in Asia-Pacific countries is boosting the market growth in the region. Asia-Pacific region is growing due to large population with prevalence of varied dise...

Immunohistochemistry transmitters are those monoclonal antibodies which have the ability to detect any particular protein in the tissue sections. This is specially designed for the identification of any tumour or disease.

The growing awareness amongst the physicians and patients regarding the benefits associated with the usage of transmucosal drug delivery devices has been directly impacting the growth of transmucosal drug delivery devices market.

Security concern and data breaching, high investment for set up of patient portal are acting as a market restraint for the growth of app-enabled patient portals during the above mentioned forecast period. On the other hand, increasing problem of health li...

Intense and deep research for the cure and prevention of cancer, tumors and cysts will also propel the market growth for coming next seven years.

The increased prevalence of sleep disorders such as sleep apnea, insomnia and narcolepsy across the globe is driving the sleep disorder treatment market.

The advanced organizations have launched superior encryption technologies which will act as the opportunity for market growth.

On the other hand, increasing number of applications from emerging economies along with rising demand for personalized medicines and protein therapeutics which will further contribute by generating immense opportunities that will led to the growth of the...